Geneos Wealth Management Inc. - PLIANT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,754
-4.3%
3,1000.0%0.00%0.0%
Q2 2023$56,172
-31.9%
3,1000.0%0.00%
-40.0%
Q1 2023$82,460
+37.6%
3,1000.0%0.01%
+25.0%
Q4 2022$59,923
-6.4%
3,1000.0%0.00%0.0%
Q3 2022$64,000
+178.3%
3,1000.0%0.00%
+300.0%
Q2 2022$23,000
+9.5%
3,1000.0%0.00%0.0%
Q1 2022$21,000
-48.8%
3,1000.0%0.00%
-50.0%
Q4 2021$41,000
-22.6%
3,1000.0%0.00%0.0%
Q3 2021$53,000
-39.1%
3,1000.0%0.00%
-33.3%
Q2 2021$87,000
-15.5%
3,1000.0%0.00%0.0%
Q1 2021$103,000
-15.6%
3,1000.0%0.00%
-40.0%
Q4 2020$122,000
+281.2%
3,100
+106.7%
0.01%
+150.0%
Q3 2020$32,0001,5000.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 5,839,160$98,565,00018.71%
CHI Advisors LLC 2,484,724$41,942,00012.24%
TRV GP IV, LLC 2,132,867$36,003,0008.17%
Bond & Devick Financial Network, Inc. 120,160$2,028,0001.68%
Fernwood Investment Management, LLC 166,447$2,810,0000.96%
Redmile Group, LLC 3,083,501$52,049,0000.91%
HARVARD MANAGEMENT CO INC 562,379$9,493,0000.56%
Grace Capital 48,058$808,0000.50%
Eventide Asset Management 2,183,238$36,853,0000.49%
Cormorant Asset Management, LP 482,413$8,143,0000.33%
View complete list of PLIANT THERAPEUTICS INC shareholders